Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters

Database
Language
Publication year range
1.
Br J Cancer ; 124(1): 156-160, 2021 01.
Article in English | MEDLINE | ID: mdl-33024263

ABSTRACT

Brain metastases are a major cause of melanoma-related mortality and morbidity. We undertook whole-exome sequencing of 50 tumours from patients undergoing surgical resection of brain metastases presenting as the first site of visceral disease spread and validated our findings in an independent dataset of 18 patients. Brain metastases had a similar driver mutational landscape to cutaneous melanomas in TCGA. However, KRAS was the most significantly enriched driver gene, with 4/50 (8%) of brain metastases harbouring non-synonymous mutations. Hotspot KRAS mutations were mutually exclusive from BRAFV600, NRAS and HRAS mutations and were associated with a reduced overall survival from the resection of brain metastases (HR 10.01, p = 0.001). Mutations in KRAS were clonal and concordant with extracranial disease, suggesting that these mutations are likely present within the primary. Our analyses suggest that KRAS mutations could help identify patients with primary melanoma at higher risk of brain metastases who may benefit from more intensive, protracted surveillance.


Subject(s)
Brain Neoplasms/genetics , Brain Neoplasms/secondary , Melanoma/genetics , Proto-Oncogene Proteins p21(ras)/genetics , Skin Neoplasms/genetics , DNA Mutational Analysis , Humans , Mutation , Recurrence , Melanoma, Cutaneous Malignant
2.
Mech Ageing Dev ; 133(1): 1-10, 2012 Jan.
Article in English | MEDLINE | ID: mdl-22155175

ABSTRACT

Various studies have demonstrated longevity effects of flavonoids, a major sub-group of plant polyphenolic compounds, in Caenorhabditis elegans. To better understand their structure-activity relationship in vivo we have used a comparative approach by exposing C. elegans to the structurally related flavonoids myricetin, quercetin, kaempferol and naringenin, and assessed their impact on lifespan and on putative modes of action. The bioavailability of the tested flavonoids was demonstrated by high-performance liquid chromatography with diode-array detection (HPLC/DAD) and a 2-aminoethyl diphenyl borate-based in vivo approach. While all flavonols increased lifespan in wild-type, only myricetin elongated the mev-1(kn1) lifespan, suggesting that the flavonols antioxidant action alone is not sufficient for longevity. Structural prerequisites of high antioxidant action in vitro were also essential to reduce the reactive oxygen species (ROS) load in vivo in C. elegans and were tested in isolated mouse muscle mitochondria. Since the insulin/IGF-like signaling (IIS) cascade is a key regulator of lifespan, all compounds were tested for the ability to cause nuclear translocation of the FOXO transcription factor DAF-16 and changes in target gene expression. An increased DAF-16 translocation and sod-3 promoter activity were observed with all flavonoids but was independent of their ROS scavenging capability and their effects on lifespan.


Subject(s)
Antioxidants/pharmacology , Caenorhabditis elegans/metabolism , Flavonoids/pharmacology , Longevity/drug effects , Animals , Antioxidants/pharmacokinetics , Caenorhabditis elegans Proteins/biosynthesis , Flavonoids/pharmacokinetics , Gene Expression Regulation/drug effects , Gene Expression Regulation/physiology , Longevity/physiology , Molecular Structure , Reactive Oxygen Species/metabolism , Signal Transduction/drug effects , Signal Transduction/physiology , Structure-Activity Relationship
SELECTION OF CITATIONS
SEARCH DETAIL